Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Intuitive Surgical Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel
Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable
Accrued compensation and employee benefits
Deferred revenue
Other accrued liabilities
Current liabilities
Other long-term liabilities
Long-term liabilities
Total liabilities
Preferred stock, $0.001 par value, issuable in series; zero shares issued and outstanding
Common stock, $0.001 par value
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Total Intuitive Surgical, Inc. stockholders’ equity
Noncontrolling interest in joint venture
Total stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Accounts Payable
The accounts payable balance shows considerable volatility over the analyzed periods, starting from approximately 133.4 million USD in March 2020 and experiencing fluctuations with notable peaks towards the end of 2024. The balance rises sharply to 276.2 million USD as of March 2025, reflecting increased short-term obligations or supplier credit usage.
Accrued Compensation and Employee Benefits
This item exhibits a strong upward trend over the time frame. From 156.5 million USD in March 2020, it reaches a peak exceeding 535.6 million USD in December 2024 before slightly declining to 309.7 million USD by March 2025. The fluctuations suggest cyclical payroll or benefit accrual patterns with significant seasonal or compensation-related spikes towards year-end periods.
Deferred Revenue
Deferred revenue remains relatively stable, with minor fluctuations around the 350 to 470 million USD range. A gradual upward trend is observed, with balances increasing from 337.4 million USD in early 2020 to nearly 496.3 million USD in March 2025, indicating modest growth in prepayments or unearned revenue.
Other Accrued Liabilities
Other accrued liabilities display a notable rising trend, from 318.6 million USD in March 2020 to a high of 710.6 million USD by the end of 2023. Subsequent months show a downward correction but remain elevated above earlier levels, suggesting growing accrued expenses or contingent liabilities followed by some normalization.
Current Liabilities
Current liabilities have generally increased from 945.9 million USD at the start of 2020 to a notable peak around 1.75 billion USD in December 2024, before a drop to 1.54 billion USD by March 2025. This indicates expanding short-term obligations, though with some late-period contraction.
Other and Long-term Liabilities
Both other long-term liabilities and total long-term liabilities remain relatively flat, fluctuating slightly between 365.9 million USD and 474.6 million USD over the period. There is no clear upward or downward trend, indicating stable long-term debt or obligation levels.
Total Liabilities
Total liabilities rise consistently, from approximately 1.36 billion USD in early 2020 to a peak of 2.21 billion USD by December 2024, followed by a decrease to 2.01 billion USD in March 2025. This suggests the company has increased its total obligations substantially over the time period analyzed.
Common Stock and Additional Paid-in Capital
The common stock value remains stable at 100 to 400 thousand USD, with a step increase occurring around September 2020. Additional paid-in capital shows strong growth, from roughly 5.93 billion USD to almost 10 billion USD over the five-year span. This reflects ongoing equity injections, stock issuances, or capital contributions.
Retained Earnings
Retained earnings demonstrate a strong upward trajectory from approximately 2.57 billion USD in March 2020 to nearly 7.14 billion USD by March 2025. There is some fluctuation, particularly a dip around late 2022, but the general trend signifies sustained profitability and earnings retention.
Accumulated Other Comprehensive Income (Loss)
This account fluctuates widely with both positive and negative values. Starting with a small positive balance, it moves into substantial negative territory through 2022 and partial recovery thereafter, indicating volatility in items such as foreign currency translation adjustments or unrealized gains/losses.
Total Stockholders’ Equity
Total equity consistently grows from 8.53 billion USD in early 2020 to approximately 17.21 billion USD by March 2025. This growth reflects the combined effects of increasing retained earnings, additional paid-in capital, and accumulated other comprehensive changes, signaling a strengthening equity base.
Total Liabilities and Stockholders’ Equity
The total of liabilities and equity progressively increases, indicating overall asset growth on the balance sheet. The total expands from just under 9.89 billion USD in the first quarter of 2020 to over 19.22 billion USD by March 2025, consistent with the growth observed in both liabilities and stockholders’ equity.